Latest filing published 21 Sept 2026 for CG Oncology, Inc., €2.0M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ambaw Bellete appears in our data through filings on CG Oncology, Inc. shares, published by SEC (Form 4). We count 22 filings; the first trade dates from 15 July 2026 and the latest from 21 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 21 September 2026, reports a transaction of €2.0M in CG Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations